BioSig Technologies, Inc.
  • Home
  • About BioSig
    • Overview
    • Leadership
    • Partnerships
  • PURE EP
    • Our Solution
    • Publications
    • Physician Insights
  • Join Our Team
  • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Presentations
    • Events
    • Newsletter
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Fact Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

BioSig Installs its Signal Processing Technology for Arrhythmia Care at a Leading Hospital in Boston

November 8, 2021

BioSig Expands its Installation Base in Texas

November 4, 2021

BioSig Increases Case Volume Estimates

November 1, 2021

BioSig’s PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias

October 12, 2021

Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiovascular Electrophysiology

October 4, 2021

BioSig Selects Plexus Corp. as its Manufacturing Partner

September 28, 2021

BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors

September 21, 2021

BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System

September 13, 2021

BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium

August 31, 2021

BioSig’s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium

August 19, 2021
rss_feed News RSS
  • Previous
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...32
    Next
    Award
    BioSig Technologies, Inc.
    Sign Up for BioSig Updates Contact Us
    Twitter linkedin Facebook
    © 2023 BioSig Technologies, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap